88 results
Page 3 of 5
8-K
EX-99.1
f54rxxw6
3 Feb 21
Regulation FD Disclosure
12:00am
8-K
EX-99.1
5udb0v1hs 0khrpsch
2 Nov 20
Rhythm Pharmaceuticals Reports Third Quarter 2020 Financial Results
9:32am
8-K
EX-99.1
nwe16ltlzc uwgr
3 Aug 20
Rhythm Pharmaceuticals Reports Second Quarter 2020 Financial Results
9:25am
8-K
EX-99.1
cglhs rr3t
10 Jan 20
Regulation FD Disclosure
8:46am
8-K
EX-99.1
oodym0mube2
6 Nov 19
Rhythm Pharmaceuticals Announces Late-breaking Data from Phase 3 Trials of Setmelanotide in POMC and LEPR Deficiency Obesities at ObesityWeek 2019
9:28am
8-K
EX-1.1
oxnl1yjggbipc0pi
16 Oct 19
Rhythm Pharmaceuticals, Inc. Announces Proposed Public Offering
5:27pm
424B5
tq29d
16 Oct 19
Prospectus supplement for primary offering
5:25pm
424B5
7rcnurmw
15 Oct 19
Prospectus supplement for primary offering
4:51pm
8-K
EX-99.2
2nzzloi
7 Aug 19
Other Events
9:07am
8-K
EX-99.1
mqwud8uwgp8 t8n8ji
7 Aug 19
Other Events
9:07am
8-K
EX-99.1
5qw0i
29 Jul 19
Regulation FD Disclosure
4:40pm
8-K
EX-99.1
7urnfn1kx
29 Jul 19
Rhythm Pharmaceuticals Reports Second Quarter 2019 Financial Results
4:40pm
8-K
EX-99.1
2ylkg57tsj19 mtk8fv
25 Jul 19
Rhythm Pharmaceuticals Announces Appointment of Stuart Arbuckle to its Board of Directors
4:01pm